Precigen (PGEN) Earnings Date & Reports

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PGEN is expected to report earnings to fall 16.50% to -1 cents per share on August 10

Q2'26

Est.

$-0.02

Q1'26

Beat

by $0.01

Q4'25

Beat

by $0.01

Q3'25

Missed

by $0.97

Q2'25

Missed

by $0.01

The last earnings report on May 13 showed earnings per share of -1 cents, beating the estimate of -2 cents. With 3.62M shares outstanding, the current market capitalization sits at 1.58B.

View a ticker or compare two or three

Compare

PGEN

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for PGEN

A.I. Advisor